A Review of Treatment of Acute Ischemic Stroke
Abstract
Treatment strategies for acute ischaemic stroke focus on two main areas: improving blood circulation to the brain and neuropro-tection. However, these measures are only efective in the treatment of vascular stenoses. However, they are only efective within a narrow therapeutic window and are therefore limited. This article now provides a brief summary of the clinical treatment of acute ischaemic stroke and its future directions, with the aim of providing an updated direction and theoretical basis for relevant drug development.
References
[1] GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global
Burden of Disease Study 2016. Lancet Neurol. 2019 May;18(5):439-458.
[2] Guzik A, Bushnell C. Stroke Epidemiology and Risk Factor Management. Continuum (Minneap Minn). 2017 Feb;23(1, Cerebrovascular Disease):15-39.
[3] Zuo K, Yang XC, Zhong JC. Progress in the research of acute ischemic stroke injury mechanism and its therapeutic drugs[J]. Advances in Pharmacy,2019,43(08):576-583.
[4] Chamorro Á, Dirnagl U, Urra X, Planas AM. Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative
stress, and inflammation. Lancet Neurol. 2016 Jul;15(8):869-881.
[5] Jolugbo P, Ariëns RAS. Thrombus Composition and Efficacy of Thrombolysis and Thrombectomy in Acute Ischemic Stroke.
Stroke. 2021 Mar;52(3):1131-1142.
[6] Silva GS, Nogueira RG. Endovascular Treatment of Acute Ischemic Stroke. Continuum (Minneap Minn). 2020 Apr;26(2):310-331.
[7] Albers GW, Olivot JM. Intravenous alteplase for ischaemic stroke. Lancet. 2007 Jan 27;369(9558):249-50.
[8] Ahn SH, Hong R, Choo IS, Heo JH, Nam HS, Kang HG, Kim HW, Kim JH. Histologic features of acute thrombi retrieved from
stroke patients during mechanical reperfusion therapy. Int J Stroke. 2016 Dec;11(9):1036-1044.
[9] Staessens S, Denorme F, Francois O, Desender L, Dewaele T, Vanacker P, Deckmyn H, Vanhoorelbeke K, Andersson T, De Meyer
SF. Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance. Haematologica. 2020 Jan 31;105(2):498-
507.
[10]Goyal M, Menon BK, Van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of
individual patient data from five randomised trials. Lancet. 2016 Apr 23;387(10029):1723-31.
[11]Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J
Med. 2018 Feb 22;378(8):708-718.
[12]Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999 Dec 1;282(21):2003-11.
[13]Warner JJ, Harrington RA, Sacco RL, Elkind MSV. Guidelines for the Early Management of Patients With Acute Ischemic Stroke:
2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke. Stroke. 2019 Dec;50(12):3331-3332.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.
